CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate

ABSTRACT: We performed a proteomic study, using CD83 overexpression, CD83 knockdown, and control SKOV3 cells by IBT Quantification Proteomics.

ORGANISM(S): Homo Sapiens

SUBMITTER: Suren Chen  

PROVIDER: PXD013433 | iProX | Wed Apr 10 00:00:00 BST 2019

REPOSITORIES: iProX